Merit Medical (NSDQ:MMSI) said yesterday that it put $60 million on the table to acquire Vascular Insights and its ClariVein line of catheters, including a $20 million milestone pegged to sales targets. Quincy, Mass.-based Vascular Insights makes the ClariVeinIC and ClariVeinOC infusion and occlusion catheters for treating superficial venous disease. “We have had our eye on […]
Merit Medical wins FDA nod for EmboCube embolization gelatin
Merit Medical received FDA 510(k) clearance for its EmboCube embolization gelatin. EmboCube is used in the embolization of hypervascular tumors. It features uniformly cut cubes of gelatin foam that have been designed to address preparation concerns and inconsistent particle sizes that come with traditional gelatin foam sheets as an embolic. Embocube gets preloaded into a Medallion […]
Merit Medical closes $200m Cianna Medical buy
Merit Medical (NSDQ:MMSI) said yesterday that it closed its $200 million acquisition of Cianna Medical, making the company a wholly-owned subsidiary. Aliso Viejo, Calif.-based Cianna makes the Savi Scout wire-free breast tumor localization system, designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures. The device won 510(k) clearance from […]
FDA clears NinePoint Medical’s AI-powered IRIS upgrade for Nvision VLE esophageal imager
NinePoint Medical said today that it won FDA 510(k) clearance for the Intelligent Real-time Image Segmentation software upgrade for its flagship Nvision VLE imaging system. The newly cleared IRIS is an artificial intelligence-based platform for image feature segmentation, the Bedford, Mass.-based company said. The company touted that the approval was the first of its kind for […]
Merit Medical logs Q3 sales and earnings beat
Merit Medical (NSDQ:MMSI) yesterday put up third-quarter numbers that beat expectations on both sales and earnings and confirmed that it’s on track to hit the midpoint of its guidance for the rest of the year. South Jordan, Utah-based Merit posted a swing to black ink for the three months ended Sept. 30, with profits of $16.6 […]
Merit Medical to acquire Cianna Medical for up to $200m
Merit Medical (NSDQ:MMSI) said yesterday that it agreed to acquire Cianna Medical and its breast cancer localization and guidance devices for up to $200 million. Aliso Viejo, Calif.-based Cianna makes the Savi Scout wire-free breast tumor localization system, designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures. The device won […]
Merit Medical closes $217m offering
Merit Medical (NSDQ:MMSI) said yesterday that it closed a stock offering worth more than $217 million after the underwriters picked up their option. South Jordan, Utah-based Merit floated 3.5 million shares at $54 apiece and sold another 525,000 shares in the underwriter’s allotment, for gross proceeds of $217.4 million. The net proceeds of roughly $204.9 million […]
Merit Medical plots public offering
Merit Medical (NSDQ:MMSI) said yesterday that it’s planning a public offering that would reap $200 million at yesterday’s closing price. South Jordan, Utah-based Merit said it intends to float 3.5 million shares in the offering, plus a 30-day underwriters option for another 525,000 shares. Although the medical device maker hasn’t priced the offering, at yesterday’s closing […]
NinePoint Medical lifts Namati to the corner office | Personnel Moves – July 10, 2018
NinePoint Medical said earlier this month that it appointed Eman Namati as its new president and chief executive officer, succeeding Christopher von Jako who will remain on the company’s board of directors. Namati joined NinePoint Medical at its inception in 2010 as a technical co-founder, and operated as R&D VP for the past four years, […]
BD lifts Bard vet DeFord to CTO | Personnel Moves – June 4, 2018
Becton Dickinson (NYSE:BDX) said last Friday it is lifting former C.R. Bard science, technology and clinical affairs senior VP John DeFord to the role of chief technology officer and exec VP. Since acquiring Bard in a $24 billion deal that closed last December, DeFord has served as BD interventional segment R&D SVP, the Franklin Lakes, N.J.-based company […]
Merit Medical gets in on NinePoint’s NvisionVLE OCT
NinePoint Medical said today that it inked a long-term deal with Merit Medical (NSDQ:MMSI) division Endotek to distribute its NvisionVLE optical coherence tomography device that includes strategic investment of an unspecified amount. “NinePoint Medical is committed to providing GI physicians an elegant and cost-effective OCT imaging solution to enable early and accurate diagnosis,” president & CEO Christopher […]
- 1
- 2
- 3
- …
- 6
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube